Elanco Animal Health Incorporated
Stock Forecast, Prediction & Price Target
Elanco Animal Health Incorporated (ELAN) stock Price Target by analysts
$16
Potential downside: -9.37%
Elanco Animal Health Incorporated price prediction
What is Elanco Animal Health Incorporated stock analysts` prediction?
Elanco Animal Health Incorporated stock forecast: Based on 2 Wall Street analysts` predicted price targets for Elanco Animal Health Incorporated in the last 3 months, the avarage price target is $16, with a high forecast of $NaN. The average price target represents a -9.37% change from the last price of $17.66.
Disclaimer: This is not investment advice. Don't use price targets as the only investment indicator. Always remember to do your own thorough research and due diligence before making an investment decision.
Elanco Animal Health Incorporated stock Price Target by analysts
Full breakdown of analysts given Elanco Animal Health Incorporated price targets
| Analyst name & company | Analyst win rate | Publish date | Price target | Price when posted | Source | Historical targets |
|---|---|---|---|---|---|---|
Andrea Alfonso UBS | 0% 0/1 | 10 months ago | $18 1.94% upside | $12.5 | StreetInsider | Previous targets (0) |
Daniel Clark Leerink Partners | 0% 0/1 | 10 months ago | $14 -20.70% downside | $13.16 | StreetInsider | Previous targets (0) |
Balaji Prasad Barclays | 0% 0/1 | about 1 year ago | $22 24.60% upside | $14.07 | TheFly | Previous targets (0) |
David Westenberg Piper Sandler | 0% 0/4 | about 1 year ago | $16 -9.37% downside | $14.43 | TheFly | Previous targets (3) |
David Westenberg Piper Sandler | 0% 0/4 | over 1 year ago | $19 7.61% upside | $17 | StreetInsider | Previous targets (3) |
David Westenberg Piper Sandler | 0% 0/4 | over 1 year ago | $18 1.94% upside | $15.77 | StreetInsider | Previous targets (3) |
Jonathan Block Stifel Nicolaus | 0% 0/1 | over 1 year ago | $20 13.27% upside | $15.45 | StreetInsider | Previous targets (0) |
Unknown Barclays | N/A | about 3 years ago | $18 1.94% upside | $15 | Benzinga | N/A |
David Westenberg Piper Sandler | 0% 0/4 | about 3 years ago | $21 18.93% upside | $19.08 | TheFly | Previous targets (3) |
Unknown J.P. Morgan | N/A | about 3 years ago | $32 81.24% upside | $20.14 | Benzinga | N/A |
Unknown Stifel Nicolaus | N/A | over 3 years ago | $22 24.60% upside | $19.94 | Benzinga | N/A |
Unknown Goldman Sachs | N/A | over 3 years ago | $32 81.24% upside | $23.35 | Benzinga | N/A |
Unknown Morgan Stanley | N/A | over 3 years ago | $37 109.56% upside | $23.73 | Benzinga | N/A |
Elanco Animal Health Incorporated Financial Estimates
Elanco Animal Health Incorporated Revenue Estimates
Elanco Animal Health Incorporated EBITDA Estimates
Elanco Animal Health Incorporated Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $4.76B N/A | $4.41B -7.28% | $4.41B -0.02% | Avg: $4.70B Low: $4.63B High: $4.82B avg. 6.46% | Avg: $4.92B Low: $4.87B High: $5.00B avg. 4.83% | Avg: $5.20B Low: $5.15B High: $5.28B avg. 5.66% | Avg: $5.48B Low: $5.42B High: $5.56B avg. 5.25% |
Net Income
% change YoY
| $-472M N/A | $-74M 84.32% | $-1.23B -1563.51% | Avg: $65.05M Low: $49.23M High: $270.76M avg. 105.28% | Avg: $156.83M Low: $123.07M High: $354.45M avg. 141.07% | Avg: $613.73M Low: $604.76M High: $625.81M avg. 291.32% | Avg: $770.44M Low: $759.19M High: $785.60M avg. 25.53% |
EBITDA
% change YoY
| $853M N/A | $886M 3.86% | $-224M -125.28% | Avg: $857.05M Low: $844.32M High: $878.89M avg. 482.61% | Avg: $898.46M Low: $888.36M High: $912.05M avg. 4.83% | Avg: $949.36M Low: $938.69M High: $963.73M avg. 5.66% | Avg: $999.21M Low: $987.98M High: $1.01B avg. 5.25% |
EPS
% change YoY
| -$0.97 N/A | -$0.15 84.53% | -$2.5 -1566.66% | Avg: $0.25 Low: $0.1 High: $0.55 avg. 110.06% | Avg: $0.44 Low: $0.25 High: $0.72 avg. 76.42% | Avg: $1.25 Low: $1.23 High: $1.27 avg. 180.78% | Avg: $1.57 Low: $1.54 High: $1.6 avg. 25.53% |
Operating Expenses
% change YoY
| $2.32B N/A | $2.11B -9.18% | $1.61B -23.78% | Avg: $1.33B Low: $1.31B High: $1.37B avg. -16.91% | Avg: $1.40B Low: $1.38B High: $1.42B avg. 4.83% | Avg: $1.48B Low: $1.46B High: $1.50B avg. 5.66% | Avg: $1.56B Low: $1.54B High: $1.58B avg. 5.25% |
FAQ
What is Elanco Animal Health Incorporated stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 140.80% in 2025-2028.
We have gathered data from 8 analysts. Their low estimate is 49.23M, average is 65.05M and high is 270.76M.
What is Elanco Animal Health Incorporated stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 5.55% in 2025-2028.
We have gathered data from 9 analysts. Their low revenue estimate is $4.63B, average is $4.70B and high is $4.82B.
What is Elanco Animal Health Incorporated stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 98.20% in 2025-2028.
We have gathered data from 8 analysts. Their low earnings per share estimate is $0.1, average is $0.25 and high is $0.55.
What is the best performing analyst?
In the last twelve months 2 analysts have been covering Elanco Animal Health Incorporated stock. The most successful analyst is Andrea Alfonso.